Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T(2023) Robust scoring of selective drug responses for patient-tailored therapy selection Nat Protoc(in press) DOI 10.1038/s41596-023-00903-x, PubMed 37996540
Athanasiadis P, Ravikumar B, Elliott RJR, Dawson JC, Carragher NO, Clemons PA, Johanssen T, Ebner D, Aittokallio T(2023) Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cells iScience, 26(7), 107209 DOI 10.1016/j.isci.2023.107209, PubMed 37485377
Denisova OV, Merisaari J, Huhtaniemi R, Qiao X, Yetukuri L, Jumppanen M, Kaur A, Pääkkönen M, von Schantz-Fant С, Ohlmeyer M, Wennerberg K, Kauko O, Koch R, Aittokallio T, Taipale M, Westermarck J(2023) PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells Mol Oncol, 17(9), 1803-1820 DOI 10.1002/1878-0261.13488, PubMed 37458534